Rosemary Mazanet, M.D. PhD
Chair, The Columbia Care Scientific Advisory Board
Rosemary Mazanet, M.D. PhD, is an oncologist with decades of experience in biotechnology and public equity. An alumna of the Dana-Farber Cancer Institute and Brigham and Women's Hospital and early Amgen, she is a life sciences management and investment professional with hands-on executive management including IND submission through NDA approval and commercial launch. Since 2013, she has been engaged in research into the use and effectiveness of cannabinoids for clinical treatment.
Copyright © 2018 SkyBridge Capital. All rights reserved. Terms and Conditions